Cite
HARVARD Citation
MacDougall, K. et al. (n.d.). 83 The prognostic significance of peripheral blood biomarkers in patients with advanced non-small cell lung cancer treated with pembrolizumab: a clinical study. Journal for immunotherapy of cancer. p. A91. [Online].